Banner - NPPA Connect

News


All News

Dr. Cosmetic has a thriving cosmetic dermatology practice. He treats thousands of patients each year with a variety of lasers, fillers and botulinum toxins. One year ago, he treated a patient with botulinum toxin who, after paying her bill, died in his office from a heart attack. Although saddened by the death of his patient, he was somewhat comforted by the fact that his treatment had nothing to do with her untimely death.

At age 32, having just become a board-certified dermatologist, Wilma Fowler Bergfeld, M.D., was already feeling antsy about what she would tackle next. So, she set goals one lonely night at her desk, and decided that she would become the first female president of the American Academy of Dermatology (AAD).

Rx for Medicine : SGR fix in balance as Senate debates healthcare reform On the Mend? : Fillers, toxins market ‘resilient,’ due for possible bounceback, analyst says Special Report : Wound healing

Physicians' efforts to collect from patients are exponentially better nowadays, but patient statements haven't changed in decades: a slip of paper is popped into an envelope and mailed every 30 days. In this volatile, changing economy, it's time to overhaul your dermatology practice's approach to patient statements.

National report - Chandra, Jordan and Trae Berns have carried severe scars over much of their bodies since the 22-year-old triplets suffered third-degree burns in a house fire at the age of 17 months.

Berkeley Heights, N.J. - Pharmaceutical company Genta Inc., based here, announced recently that a phase 3 drug trial for the melanoma drug Genasense showed no statistically significant benefit compared with a placebo, reports news source Foxbusiness.com.

Cleveland - The National Institutes of Health has awarded Pratima Karnik, Ph.D., assistant professor of dermatology at Cleveland’s Case Western Reserve University, a grant of $1.77 million to fund a five-year study titled “PPAR-gamma Signaling in Normal Pilosebaceous Units and in Scarring Alopecia,” reports the Cicatricial Alopecia Research Foundation (CARF).

Minneapolis - Results of a recently completed study appear to establish the efficacy of Levulan Photodynamic Therapy (PDT) in reducing the recurrence of squamous cell carcinomas (SCCs) in solid organ transplant recipients (SOTRs), reports PRNewswire.

London - Researchers from Cancer Research UK's Cambridge Research Institute say they have found how two genes from the same “family” can interact to stop cancer, reports News-medical.net.